https://www.selleckchem.com/pr....oducts/etomoxir-na-s
facet joint osteoarthritis. [a]www.ClinicalTrials.gov[/a] identifier NCT02007083 , registered December 2013. [a]www.ClinicalTrials.gov[/a] identifier NCT02007083 , registered December 2013. Elagolix is effective and safe for treating menorrhagia in women with uterine fibroid. However, it is reported to be associated with hypoestrogenism that can be alleviated by adding estradiol/norethindrone acetate. This systematic review and meta-analysis aimed to determine the effectiveness of elagolix treatment in women with heavy menstrual bleeding ass
Curtir
Comentario
Compartilhar
